10-Year Multimorbidity Trajectories in Older People Have Limited Benefit in Predicting Short-Term Health Outcomes in Comparison to Standard Multimorbidity Thresholds: A Population-Based Study
Marc Simard,Elham Rahme,Marjolaine Dubé,Véronique Boiteau,Denis Talbot,Miceline Mésidor,Yohann Chiu,Caroline Sirois
DOI: https://doi.org/10.2147/clep.s456004
2024-05-23
Clinical Epidemiology
Abstract:Marc Simard, 1– 4 Elham Rahme, 5 Marjolaine Dubé, 1 Véronique Boiteau, 1 Denis Talbot, 2, 3 Miceline Mésidor, 2, 3 Yohann Moanahere Chiu, 1, 4, 6 Caroline Sirois 1, 3, 4, 6 1 Institut national de santé publique du Québec, Québec, QC, Canada; 2 Department of Social and Preventive Medicine, Faculty of Medicine, Université Laval, Québec, QC, Canada; 3 Centre de recherche du CHU de Québec, Québec, QC, Canada; 4 VITAM-Centre de recherche en santé durable, Québec, QC, Canada; 5 Department of Medicine, Division of Clinical Epidemiology, McGill University, and Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montréal, QC, Canada; 6 Faculty of de Pharmacy, Université Laval, Québec, QC, Canada Correspondence: Marc Simard, Institut national de santé publique du Québec, 945, Wolfe, 5e étage, Québec, QC, G1V 5B3, Canada, Tel +1 418 650 5115 &num5522, Fax +1 418 643 5099, Email Purpose: To identify multimorbidity trajectories among older adults and to compare their health outcome predictive performance with that of cross-sectional multimorbidity thresholds (eg, ≥ 2 chronic conditions (CCs)). Patients and Methods: We performed a population-based longitudinal study with a random sample of 99,411 individuals aged > 65 years on April 1, 2019. Using health administrative data, we calculated for each individual the yearly CCs number from 2010 to 2019 and constructed the trajectories with latent class growth analysis. We used logistic regression to determine the increase in predictive capacity ( c-statistic ) of multimorbidity trajectories and traditional cross-sectional indicators (≥ 2, ≥ 3, or ≥ 4 CCs, assessed in April 2019) over that of a baseline model (including age, sex, and deprivation). We predicted 1-year mortality, hospitalization, polypharmacy, and frequent general practitioner, specialist, or emergency department visits. Results: We identified eight multimorbidity trajectories, each representing between 3% and 25% of the population. These trajectories exhibited trends of increasing, stable, or decreasing number of CCs. When predicting mortality, the 95% CI for the increase in the c-statistic for multimorbidity trajectories [0.032– 0.044] overlapped with that of the ≥ 3 indicator [0.037– 0.050]. Similar results were observed when predicting other health outcomes and with other cross-sectional indicators. Conclusion: Multimorbidity trajectories displayed comparable health outcome predictive capacity to those of traditional cross-sectional multimorbidity indicators. Given its ease of calculation, continued use of traditional multimorbidity thresholds remains relevant for population-based multimorbidity surveillance and clinical practice. Keywords: multimorbidity, trajectories, prevalence, health outcome prediction, population-based In the last decades, the rise in life expectancy and the increasing prevalence of many chronic conditions have contributed to a heightened number of individuals coping with multiple chronic conditions, constituting a growing global public health challenge. 1,2 Multimorbidity, the coexistence of two or more chronic conditions within the same individual, exerts adverse effects both on individual health and the healthcare system. 3 It is indeed associated with higher risks of psychological distress, poor quality of life, polypharmacy, mortality, and heightened healthcare utilization, including hospitalization, outpatient visits and emergency department (ED) visits. 3 Public health authorities and health agencies utilize multimorbidity indicators, based on the prevalence of multiple chronic conditions, to monitor the burden of multimorbidity and allocate resources for the management and prevention of chronic diseases. 4 These indicators rely on cross-sectional count of chronic conditions, with most of them assessing the prevalence of individuals with at least two (≥2) or at least three (≥3) chronic conditions. 5 Indicators that capture the cooccurrence of multiple chronic conditions are also useful for clinical practice where treatment guidelines account for multimorbidity. 6 Longitudinal approaches to assess multimorbidity, such as multimorbidity trajectories, are an emerging research area. 7 A multimorbidity trajectory identifies a subgroup of the population characterized by the number and the speed of onset of chronic conditions. Individuals in multimorbidity trajectories with a rapid onset or a high number of chronic conditions face an increasing risk o -Abstract Truncated-
public, environmental & occupational health